Lung cancer, liver cancer, esophageal cancer etc.
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Cases of heavy particle therapy for thoracic (upper abdominal) cancer patients between April 1994 and March 2021 in QST hospital.
Exclusion criteria
Exclusion criteria: Cases in which the secondary use of clinical data is refused at the time of obtaining consent for treatment or other research, and cases in which the research subject or his/her representative refuses the use of clinical data for this research.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rate of adverse cardiac events | — |
Secondary
| Measure | Time frame |
|---|---|
| Association between cardiac radiation dose and occurrence of adverse cardiac events | — |
Countries
Japan
Contacts
National Institute for Quantum and Radiological Science and Technology QST Hospital